文献速递中医内科中药与中成药合理使用中医康复

台湾帕金森病患者中药使用与骨折风险的关联

Utilization of Chinese herbal medicine and its association with the risk of fracture in patients with Parkinson's disease in Taiwan.
PubMed 文献 · J Ethnopharmacol · 2018-08-15

本研究基于台湾全民健康保险研究数据库,纳入1997至2010年新诊断帕金森病且年龄大于40岁的患者,比较中药使用者与非使用者的骨折风险。结果显示,中药队列骨折发生率较低(调整风险比0.5,95%CI 0.44-0.56),核心处方包括石菖蒲、远志、贝母、海螵蛸和天麻。

要点

  • 中药辅助治疗与帕金森病患者骨折风险降低相关(调整HR 0.5)。
  • 核心中药处方为石菖蒲、远志、贝母、海螵蛸和天麻。
  • 研究为回顾性队列,需前瞻性研究验证因果关系。

核心结论

  • 中药辅助治疗与帕金森病患者骨折风险降低相关。

研究设计与样本

  • 回顾性队列研究,使用台湾全民健康保险研究数据库,纳入1997-2010年新诊断帕金森病且年龄大于40岁的患者,随访至2013年底,按年龄、性别、索引年及初诊年1:1频率匹配中药使用者与非使用者。

主要发现

  • 共纳入7197例新诊断帕金森病患者,其中中药使用者3456例,非使用者3730例;匹配后比较2007例患者。
  • 中药队列骨折发生率较低,调整风险比0.5(95%CI 0.44-0.56)。
  • 中药队列骨折累积发生率较低(log-rank检验,p < 0.0001)。
  • 核心中药处方包括石菖蒲、远志、贝母、海螵蛸和天麻。

临床怎么用

  • 对于帕金森病患者,可考虑在常规治疗基础上结合中药辅助治疗以降低骨折风险。
  • 处方时可参考核心中药组合:石菖蒲、远志、贝母、海螵蛸、天麻。

局限性

  • 本研究为回顾性队列研究,可能存在未测量的混杂因素。
  • 研究基于台湾人群数据库,结论外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

ETHNOPHARMACOLOGICAL RELEVANCE: Traditional Chinese medicine (TCM) has been used for over two thousand years to treat motor impairments corresponding to the clinical manifestations of Parkinson's disease (PD). AIM OF THE STUDY: This study aimed to investigate the prescription of Chinese herbal medicine (CHM) for the management of PD and further determine whether CHM can improve motor function and decrease the risk of incident fracture. MATERIALS AND METHODS: Patients older than 40 years newly diagnosed with PD between January 1997 and December 2010 were selected from the National Health Insurance Research Database (NHIRD) and followed up until the end of 2013. We used 1:1 frequency matching by age, sex, index year, and initial diagnostic year to compare the TCM users and non-TCM users. We used a Cox regression model and the Kaplan-Meier method to estimate the risk of developing fracture among the TCM and non-TCM users. RESULTS: In total, 7197 patients older than 40 years were newly diagnosed with PD between 1997 and 2010 in Taiwan. Among these patients, 3456 were TCM users, and 3730 were non-TCM users. We compared 2007 PD patients with comparable demographic characteristics and comorbidity profiles between the two cohorts. During the follow-up period, compared with the non-TCM cohort, fewer patients in the TCM cohort had incident fractures (adjusted hazard ratio: 0.5, 95% CI: 0.44-0.56). The cumulative incidence of fracture was lower in the TCM cohort (log-rank test, p < 0.0001). Shi-Chang-Pu (Acorus gramineus Aiton), Yuan-Zhi (Polygala tenuifolia Willd), Bei-Mu (Fritillaria cirrhosa D. Don), Hai-Piao-Xiao (Sepiella maindronide Rochebrune; Sepia esculenta Hoyle), and Tian-Ma (Gastrodia elata Blume) constituted the core Chinese herbal medicine prescriptions used to treat PD patients. CONCLUSIONS: The present study identified the core prescription pattern for the management of PD in Taiwan. Complementary CHM therapy was associated with a reduced risk of fracture in PD patients.

来源:J Ethnopharmacol,查看原文。版权归原作者所有。

引用

  1. Chen KY, Wu MY, Yang PS, et al. Utilization of Chinese herbal medicine and its association with the risk of fracture in patients with Parkinson's disease in Taiwan. J Ethnopharmacol. 2018. PMID: 30118835. doi:10.1016/j.jep.2018.08.021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。